Paired with Roche's HPV testing offerings, the deal will expand its cervical cancer testing capabilities.
The German-based company expects to file its test for FFPE within the next few months, and to start a clinical trial for its cytology test by mid-year.
The funds will be used to support clinical trials and commercialization efforts, as well as US regulatory clinical trials for a PMA submission for its CINtec Plus Cytology platform.
The CTAF recommendation is "an important decision-making resource for clinicians and patients," the firm's CEO said.
Patents awarded to GeneNews, US Army, Aisin Seiki, MTM Laboratories, and USC.
A new study finds that a placental protein linked with preeclampsia can be targeted by RNA silencing, according to the New Scientist.
A settlement is expected in a Duke University lawsuit hinging on using falsified data to win grants, Retraction Watch and Science report.
In PNAS this week: approach for analyzing the expression of endogenous retroviruses, circular RNAs that influence host-virus interactions, and more.
A phylogenetic analysis finds that the rare hemimastigotes form their own supra-kingdom, CBC reports.